Languages:
Translate with Google:
TMF QIN

Medication Safety Network

Network Overview

National estimates suggest that adverse drug events (ADEs) contribute an additional $3.5 billion to U.S. health care costs. Given the U.S. population’s large and ever-increasing magnitude of medication exposure, the potential for harm from ADEs are a critical patient safety and public health challenge.
The Medication Safety Network is working with providers, pharmacists, pharmacies and stakeholders to reduce and monitor ADE rates.

A Community-Based Approach

To reduce and prevent the incidence of ADEs, we are convening community groups throughout the region that treat Medicare Fee-for-Service (FFS) beneficiaries taking three or more medications, including at least one of these high-risk medications: anticoagulants, diabetic agents and/or opioids.

Our goals include reducing ADEs by 35 percent per 1,000 screened Medicare FFS beneficiaries by 2019, and to monitor ADE rates in these patients on anticoagulants, diabetic agents or opioids by care setting, state, region and readmission rate. View our fact sheet (PDF) for an expanded view of our project.

Why Participate?

Our consultants work directly with you and your staff to implement solutions and interventions to bring about lasting change in your facility and community. As a member of the Medication Safety Network, you work with industry experts to:

  • Increase patient-centered care by coordinating provider communication regarding evidence-based medication therapy management and medication reconciliation across care settings
  • Develop and utilize ADE prevention toolkits in all care settings
  • Develop and utilize data reports that track ADE rates by beneficiary on anticoagulants, diabetic agents and opioids for participating community partners and providers

By joining our network your organization receives:

  • Inclusion in an “all participate, all learn” collaborative with peer organizations
  • Structured exchanges of information in live, web-based and online formats
  • Free educational opportunities including conferences and webinars
  • Practical insight on the complexities of adapting interventions
  • Positive reinforcement of participants’ contributions gleaned from field experience and innovations
  • A relentless focus on finding new ways to help providers and creating value for the participants

Download this fact sheet (PDF) and view these videos to learn more about how you or your facility will benefit from joining the Medication Safety Network.

Join the Medication Safety Network

All providers are encouraged to join our network to help reduce ADEs for all patients and facilities. To join, click here to create a free website account and follow the prompts.

2012 Texas Physician Practice Quality Improvement Award button.    TMF Quality Innovation Network Quality Improvement Organization   Louise H Batz Patient Safety Organization 


Quick Links

Download these resources to learn more about the Medication Safety Network.

View resources for patients and families.

Contact Information


Contact Us
Medication Safety
1-866-439-6863
Fax: 512-334-1775
MedicationSafety@tmf.org

State Contacts
Arkansas
Julie Kettlewell
State Program Director

Niki Carver, PharmD
TMF Pharmacist Consultant

Missouri
Dorothy Andrae
State Program Director

Dana Lammert
Program Manager

Oklahoma
Gayla Middlestead
State Program Director

Puerto Rico
Giovanna Fox
Puerto Rico Program Director

Ilia Ferrer
Program Lead

Texas
Vanessa Andow
Project Director

Jim Turpin
Project Director

×
April 22 MAT Waiver Training - Missouri
Medication-assisted treatment waiver training is available for Missouri physicians, nurse practitioners and physician assistants interested in seeking to apply for their waiver to prescribe buprenorphine in the treatment of opioid use disorders. To obtain the waiver to prescribe buprenorphine, providers are required to take eight hours of training. This event will take place on April 22, 2017, from 8 a.m. - 5 p.m. CT, at the St. Charles Convention Center, 1 Convention Center Plaza, St. Charles, Missouri. Registration is free; photo ID required. Register today. CME available.
May 13 MAT Waiver Training - Missouri
Medication-assisted treatment waiver training is available for Missouri physicians, nurse practitioners and physician assistants interested in seeking to apply for their waiver to prescribe buprenorphine in the treatment of opioid use disorders. To obtain the waiver to prescribe buprenorphine, providers are required to take eight hours of training. This event will take place on May 13, 2017, from 8 a.m. - 5 p.m. CT, at the Adams Pointe Conference Center & Courtyard Marriott, 1400 NE Coronado Drive, Blue Springs, Missouri. Registration is free; photo ID required. Register today. CME available.
Texas • Arkansas • Missouri • Oklahoma • Puerto Rico